Literature DB >> 6247160

Structure-activity relationships of enkephalin analogs at opiate and enkephalin receptors: correlation with analgesia.

Y Audigier, H Mazarguil, R Gout, J Cros.   

Abstract

We have investigated the influence of physico-chemical parameters (chemical structure and lipophilicity), biochemical properties (catabolism, affinity for 3H-etorphine binding sites and 3H-(D-Ala)2-Leu5-enkephalin amide binding sites) and biological activity in isolated organs (guinea-pig ileum and mouse vas deferens) on the regulation of analgesia induced after intracerebroventricular injection of various enkephalin analogs. The selectivity of these metabolically stable analogs for micro- and beta-receptors, present in guinea-pig ileum and mouse vas deferens respectively, depends on the C-terminal amino acid and also on the nature of the second D-amino-acid. A strong correlation exists between activity in guinea-pig ileum and affinity for 3H-etorphine binding sites suggesting that these sites in rat brain have properties identical to those of micro-receptors characterized in guinea-pig ileum. Similarly, the affinity for 3H-(D-Ala)2-Leu5-enkephalin amide binding sites in mouse brain is correlated to the activity in mouse vas deferens and suggests that central beta-receptors are not different from peripheral beta-receptors. If we consider morphine-like drugs and enkephalin analogs containing the same C-terminal amino acid as the enkephalins, there is a good correlation between activity on micro-receptors (affinity for 3H-etorphine binding sites and activity in guinea-pig ileum) and the antinociceptive activity. These results support the hypothesis that micro-receptors are strongly involved in the analgesic effect. However, when proline is the C-terminal amino acid, the antinociceptive activity was enhanced without any concomitant increase in the affinity. This activity enhancement was the same for each analog and a similar correlation (identical to what was found with other opioid peptides and opiates) could still be established. The reason for such a potentiation of the activity remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6247160     DOI: 10.1016/0014-2999(80)90114-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Conditioning of morphine-induced taste aversion and analgesia.

Authors:  J S Miller; K S Kelly; J L Neisewander; D F McCoy; M T Bardo
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Analgesic cross-tolerance between morphine and opioid peptides.

Authors:  S P Sivam; I K Ho
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

3.  The importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists.

Authors:  Takashi Yamamoto; Padma Nair; Neil E Jacobsen; Peg Davis; Shou-wu Ma; Edita Navratilova; Sharif Moye; Josephine Lai; Henry I Yamamura; Todd W Vanderah; Frank Porreca; Victor J Hruby
Journal:  J Med Chem       Date:  2008-09-27       Impact factor: 7.446

4.  Antinociceptive effects of two deltorphins analogs in the tail-immersion test in rats.

Authors:  J H Kotlinska; E Gibula-Bruzda; E Witkowska; N N Chung; P W Schiller; J Izdebski
Journal:  Peptides       Date:  2012-11-23       Impact factor: 3.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.